 Home > Medical News > Latest Medical News > Novo Nordisk's basal insulin GLP-1RA injection Novo benefit® was approved in China

Novo Nordisk's basal insulin GLP-1RA injection Novo benefit® was approved in China

 Last Update: 2021-11-11
 Source: Internet
 Author: User

Tags

1 2 foam

proliferation phase

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[5] Veelen A, et al.
Mol Metab.
2021 Apr;46:101158.

[6] Harris SB, et al.
Diabetes Obes Metab.
2017 Jun;19(6):858-865.

[7] Buse JB, et al.
Diabetes Care.
2014 Nov;37(11):2926-33.

[8] Lingvay I, et al.
JAMA.
2016 Mar 1;315(9):898-907.

[9] Philis-Tsimikas A, et al.
Diabetes Obes Metab.
2019 Jun;21(6):1399-1408.

[10] Billings LK, et al.
Diabetes Care.
2018 May;41(5):1009-1016.

[11] Diabetes Branch of Chinese Medical Association.
Chinese Journal of Diabetes.
2021; 13(4):315-409.

[12] Yongze Li, et al.
BMJ.
2020 Apr 28;369:m997.

[13] Wang L, et al.
JAMA.
2017 Jun 27;317(24):2515-2523.

[14] Cernea S, Raz I.
Diabetes Care.
2011 May;34 Suppl 2(Suppl 2):S264-71.

[15] Østergaard L, et al.
Expert Rev Clin Pharmacol.
2017 Jun;10(6):621-632.

[16] Miller E, et al.
Diabetes Obes Metab.
2019 Dec;21(12):2643-2650.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.